Connection

William Spencer to Humans

Back to Details
This is a "connection" page, showing publications William Spencer has written about Humans.
William Spencer
Connection Strength
0.254
Humans
  1. Determination of the best early warning scores to predict clinical outcomes of patients in the emergency department. Emerg Med J. 2019 Dec; 36(12):716-721.
    View in: PubMed
    Score: 0.026
  2. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry. J Am Coll Cardiol. 2011 Nov 22; 58(22):2322-8.
    View in: PubMed
    Score: 0.015
  3. Follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy the Baylor and Medical University of South Carolina experience 1996 to 2007. JACC Cardiovasc Interv. 2008 Oct; 1(5):561-70.
    View in: PubMed
    Score: 0.012
  4. A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy--the Baylor experience (1996-2002). Clin Cardiol. 2005 Mar; 28(3):124-30.
    View in: PubMed
    Score: 0.010
  5. Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 10; 109(5):e27-8.
    View in: PubMed
    Score: 0.009
  6. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: short-term results in 50 consecutive procedures. Clin Cardiol. 2003 Jun; 26(6):275-9.
    View in: PubMed
    Score: 0.008
  7. T wave alternans for ventricular arrhythmia risk stratification. Curr Opin Cardiol. 2003 Jan; 18(1):1-5.
    View in: PubMed
    Score: 0.008
  8. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am Heart Hosp J. 2003; 1(1):83-90.
    View in: PubMed
    Score: 0.008
  9. Percutaneous transluminal septal reduction for hypertrophic obstructive cardiomyopathy: report from an international pilot study. J Med Syst. 2002 Aug; 26(4):293-300.
    View in: PubMed
    Score: 0.008
  10. Role of controlled septal infarct in hypertrophic obstructive cardiomyopathy. Cardiol Rev. 2002 Mar-Apr; 10(2):108-18.
    View in: PubMed
    Score: 0.008
  11. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Nov 15; 38(6):1701-6.
    View in: PubMed
    Score: 0.008
  12. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001 Mar 20; 103(11):1492-6.
    View in: PubMed
    Score: 0.007
  13. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J Am Coll Cardiol. 2000 Sep; 36(3):852-5.
    View in: PubMed
    Score: 0.007
  14. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy: the need for a registry. Circulation. 2000 Aug 08; 102(6):600-1.
    View in: PubMed
    Score: 0.007
  15. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999 Oct; 34(4):1123-8.
    View in: PubMed
    Score: 0.007
  16. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 1999 Jan 26; 99(3):344-7.
    View in: PubMed
    Score: 0.006
  17. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1998 Oct 27; 98(17):1750-5.
    View in: PubMed
    Score: 0.006
  18. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1998 Jul; 32(1):225-9.
    View in: PubMed
    Score: 0.006
  19. Subclavian venogram as a guide to lead implantation. Pacing Clin Electrophysiol. 1998 Mar; 21(3):499-502.
    View in: PubMed
    Score: 0.006
  20. Atrial septal pacing: a method for pacing both atria simultaneously. Pacing Clin Electrophysiol. 1997 Nov; 20(11):2739-45.
    View in: PubMed
    Score: 0.006
  21. Hypertrophic obstructive cardiomyopathy: alternative therapeutic options. Clin Cardiol. 1997 May; 20(5):417-8.
    View in: PubMed
    Score: 0.006
  22. Pacing therapy for atrial tachyarrhythmias. Clin Cardiol. 1996 Sep; 19(9):737-42.
    View in: PubMed
    Score: 0.005
  23. Malposition of transvenous pacing lead in the left ventricle. Clin Cardiol. 1996 Apr; 19(4):335-8.
    View in: PubMed
    Score: 0.005
  24. Comparison of ventricular function in atrial rate adaptive versus dual chamber rate adaptive pacing during exercise. Pacing Clin Electrophysiol. 1994 Feb; 17(2):179-85.
    View in: PubMed
    Score: 0.004
  25. Rate augmentation and atrial arrhythmias in DDDR pacing. Pacing Clin Electrophysiol. 1990 Dec; 13(12 Pt 2):1847-51.
    View in: PubMed
    Score: 0.004
  26. Defibrillation thresholds in hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2011 May; 22(5):569-72.
    View in: PubMed
    Score: 0.004
  27. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008 Nov 18; 52(21):1718-23.
    View in: PubMed
    Score: 0.003
  28. Initial experience with alcohol septal ablation using a novel magnetic navigation system. J Interv Cardiol. 2007 Dec; 20(6):559-63.
    View in: PubMed
    Score: 0.003
  29. Depression, anxiety, and quality of life in patients with obstructive hypertrophic cardiomyopathy three months after alcohol septal ablation. Am J Cardiol. 2007 Nov 15; 100(10):1592-7.
    View in: PubMed
    Score: 0.003
  30. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007 Aug 21; 50(8):795-8.
    View in: PubMed
    Score: 0.003
  31. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2005 Dec; 28(12):1354-6.
    View in: PubMed
    Score: 0.003
  32. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease. Am J Cardiol. 2005 Aug 15; 96(4):580-1.
    View in: PubMed
    Score: 0.002
  33. Plasma monitoring of the myocardial specific tissue inhibitor of metalloproteinase-4 after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Card Fail. 2005 Mar; 11(2):124-30.
    View in: PubMed
    Score: 0.002
  34. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004 Feb 24; 109(7):824-7.
    View in: PubMed
    Score: 0.002
  35. Impact of infarct size on clinical and echocardiographic outcome in patients undergoing nonsurgical septal reduction therapy. Am Heart J. 2003 Dec; 146(6):1112-4.
    View in: PubMed
    Score: 0.002
  36. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003 Nov 05; 42(9):1687-713.
    View in: PubMed
    Score: 0.002
  37. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003 Jul 16; 42(2):296-300.
    View in: PubMed
    Score: 0.002
  38. Release of matrix metalloproteinases following alcohol septal ablation in hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2002 Dec 18; 40(12):2165-73.
    View in: PubMed
    Score: 0.002
  39. Gated SPECT in patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol. 2002 Nov-Dec; 9(6):594-600.
    View in: PubMed
    Score: 0.002
  40. Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2002 Jul 23; 106(4):412-5.
    View in: PubMed
    Score: 0.002
  41. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy. Circulation. 2001 Apr 10; 103(14):1844-50.
    View in: PubMed
    Score: 0.002
  42. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001 Jan; 37(1):208-14.
    View in: PubMed
    Score: 0.002
  43. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 1999 Jan 19; 99(2):254-61.
    View in: PubMed
    Score: 0.002
  44. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: an abridged version of the report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Mayo Clin Proc. 1997 Jun; 72(6):524-31.
    View in: PubMed
    Score: 0.001
  45. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 1996 Mar 15; 27(4):910-48.
    View in: PubMed
    Score: 0.001
  46. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Circulation. 1996 Mar 15; 93(6):1278-317.
    View in: PubMed
    Score: 0.001
  47. Steroid elution improves the stimulation threshold in an active-fixation atrial permanent pacing lead. A randomized, controlled study. Model 4068 Investigators. Circulation. 1995 Nov 15; 92(10):2935-9.
    View in: PubMed
    Score: 0.001
  48. Apex cardiogram in patients with prolapsing mitral valve. Am J Cardiol. 1973 Sep 07; 32(3):276-82.
    View in: PubMed
    Score: 0.001
  49. Bleeding complications following initiation of thrombolytic therapy for acute myocardial infarction: a comparison of helicopter-transported and nontransported patients. Ann Emerg Med. 1991 Aug; 20(8):892-5.
    View in: PubMed
    Score: 0.001
  50. Helicopter transport of patients with acute myocardial infarction. Tex Med. 1988 Oct; 84(10):35-7.
    View in: PubMed
    Score: 0.001
  51. Long-term assessment of unipolar and bipolar stimulation and sensing thresholds using a lead configuration programmable pacemaker. J Am Coll Cardiol. 1985 May; 5(5):1198-204.
    View in: PubMed
    Score: 0.001
  52. Results of coronary bypass more than 5 years after operation in 434 patients. Clinical, treadmill exercise and angiographic correlations. Am J Cardiol. 1977 Nov; 40(5):665-72.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.